Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
It can influence pro-inflammatory molecules like interleukin-6 (IL-6) and TNF-alpha, which are linked to prolonged inflammation in injury models
Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies are only allowed to use certain bulk drug substances
ARA-290 received FDA Orphan Drug Designation for this indication TRPV1-mediated pain models ARA-290 demonstrated specific inhibition of TRPV1 channel activity, relieving capsaicin-induced mechanical hypersensitivity in pre-clinical nociceptor models Complex Regional Pain Syndrome (CRPS) investigational studies have examined ARA-290 in CRPS models due to its dual anti-inflammatory and nociceptor-targeting mechanism Chronic neuropathic pain multiple studies confirm ARA-290 reduces neuroinflammation in the spinal cord by suppressing TNF-, IL-1, and other pro-inflammatory cytokines that maintain chronic pain states Neuroprotection and CNS Research: Cerebral ischaemia/stroke models Wang et al
The products should not be used as a food, drug, cosmetic, or other household use
In research settings, scientists examine BPC-157 / TB-500 Blend Capsules to evaluate their potential influence on cellular processes
US$ 25.73
US$ 21.66
US$ 21.32
US$ 20.44
US$ 29.86
US$ 26.94
US$ 24.74
